Omicron: Covid-19 antibody treatment ‘holds up well’ against new strain, Brii Biosciences says

//Omicron: Covid-19 antibody treatment ‘holds up well’ against new strain, Brii Biosciences says

Omicron: Covid-19 antibody treatment ‘holds up well’ against new strain, Brii Biosciences says

The developer of China’s first approved Covid-19 antibody cocktail said lab tests had found the treatment “holds up well” against the new Omicron variant, though one of the antibodies had a “substantial drop in activity”.Brii Biosciences on Sunday also again said its therapy “retains activity” against major coronavirus strains including the highly transmissible Delta variant and its sub-lineage Delta Plus.China’s medical products regulator approved its use last Wednesday. The company said the…

Article by [author-name] (c) China - South China Morning Post - Read full story here.

By | 2021-12-13T07:31:21+00:00 December 13th, 2021|Headlines|Comments Off on Omicron: Covid-19 antibody treatment ‘holds up well’ against new strain, Brii Biosciences says